Replies to post #11551 on Titan Pharmaceuticals Inc (TTNP)

[Doctor Detroit]

I agree that if the board was being honest with itself, it would quickly determine that Pro Neura would best be left with an organization that has the capability to execute.

To me, the most disheartening news in the past quarter was the bungled IND for Parkinson's. After a pre-IND meeting with the FDA and 16 months of development following that, they still filed an incomplete application. There are simply not enough people at Titan to catch all the mistakes that can occur. A buyout is the best solution.